Therapy in hereditary angioneurotic oedema
- PMID: 4213636
- PMCID: PMC1648996
- DOI: 10.1136/adc.49.8.636
Therapy in hereditary angioneurotic oedema
Abstract
Two branches of a family suffering from hereditary angioneurotic oedema underwent trials of therapy of ε-amino caproic-acid (EACA) to ascertain the optimum dosage required to alleviate symptoms without giving rise to unpleasant side effects.
It was found that children under 11 years tolerated 3 g/day and patients over 11 years 6 g/day without side effects, but with incomplete control of symptoms in some of the patients. However, if the dose was doubled for a period of less than 4 days during times of expected and experienced trauma, better control was achieved and unpleasant muscle cramps were not experienced. These doses, though effective, were much smaller than those used in previous studies.
Similar articles
-
Hereditary angioneurotic oedema in three families. Symptomatic heterogeneity, complement analysis and therapeutic trials.Acta Med Scand. 1972 Mar;191(3):209-19. Acta Med Scand. 1972. PMID: 5033711 No abstract available.
-
Hereditary angio-neurotic oedema. Genealogical and immunological studies.Ann Clin Res. 1973 Jun;5(3):174-80. Ann Clin Res. 1973. PMID: 4201374 No abstract available.
-
Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study.N Engl J Med. 1972 Apr 13;286(15):808-12. doi: 10.1056/NEJM197204132861503. N Engl J Med. 1972. PMID: 4551861 Clinical Trial. No abstract available.
-
Hereditary angio-oedema: a review with particular reference to pathogenesis and treatment.Clin Allergy. 1971 Jun;1(2):221-33. doi: 10.1111/j.1365-2222.1971.tb03021.x. Clin Allergy. 1971. PMID: 4274092 Review. No abstract available.
-
[Cl inhibitor deficiency in patients with hereditary angioneurotic edema].Pol Arch Med Wewn. 1974 Jun;51(6):619-28. Pol Arch Med Wewn. 1974. PMID: 4600279 Review. Polish. No abstract available.
Cited by
-
Canadian hereditary angioedema guideline.Allergy Asthma Clin Immunol. 2014 Oct 24;10(1):50. doi: 10.1186/1710-1492-10-50. eCollection 2014. Allergy Asthma Clin Immunol. 2014. PMID: 25352908 Free PMC article.
-
The International/Canadian Hereditary Angioedema Guideline.Allergy Asthma Clin Immunol. 2019 Nov 25;15:72. doi: 10.1186/s13223-019-0376-8. eCollection 2019. Allergy Asthma Clin Immunol. 2019. PMID: 31788005 Free PMC article. Review.
-
The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.World Allergy Organ J. 2022 Apr 7;15(3):100627. doi: 10.1016/j.waojou.2022.100627. eCollection 2022 Mar. World Allergy Organ J. 2022. PMID: 35497649 Free PMC article.
-
Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency).J Clin Pathol. 2002 Apr;55(4):266-70. doi: 10.1136/jcp.55.4.266. J Clin Pathol. 2002. PMID: 11919209 Free PMC article. Review.
-
C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option.Clin Exp Immunol. 2007 Jan;147(1):11-7. doi: 10.1111/j.1365-2249.2006.03256.x. Clin Exp Immunol. 2007. PMID: 17177958 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources